Form 4 for PLRX PLIANT THERAPEUTICS, INC.
Accepted 2023-01-25 00:00:00 ET · period of report 2023-01-23 · accession 0001140361-23-002783 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-25 | 2023-01-23 | PLRX | Cummings Keith Lamont | CFO | M - OptEx | $4.50 | +30.0K | 96.9K | +45% | +$134.8K |
| D | 2023-01-25 | 2023-01-23 | PLRX | Cummings Keith Lamont | CFO | S - Sale+OE | $35.00 | -30.0K | 84.4K | -26% | -$1.05M |
| DM | 2023-01-25 | 2023-01-23 | PLRX | Cummings Keith Lamont | CFO | M - OptEx | $0.00 | -30.0K | 18.2K | -62% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-23 | M | A | 17,500 | $6.22 | 114,424 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-23 | M | A | 12,500 | $2.08 | 96,924 | D | — | — | |
| 3 | Common | Common Stock | 2023-01-23 | S | D | 30,000 | $35.00 | 84,424 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2023-01-23 | M | D | 12,500 | $0.00 | 133,597 | D | $2.08 · — to 2029-01-23 | 12,500 Common Stock | (F2) 25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| 5 | Derivative | Stock Option (right to buy) | 2023-01-23 | M | D | 17,500 | $0.00 | 18,198 | D | $6.22 · — to 2030-03-30 | 17,500 Common Stock | (F3) 1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of March 31, 2020 (or if there is no corresponding day in any such month, on the last day of such month), subject to the Reporting Person's continuous service to the Issuer on each such date. |